Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of ...

Your silver strands might be doing more than showing your age, according to a new study out of the University of Tokyo.

Researchers at the Institut Pasteur and Inserm have developed a novel triple-therapy that reprograms how B cell cancers ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint ...

This novel STING-pathway mechanism suggests that PV-10 could potentially represent a safer, more efficacious, and differentiated alternative to widely used vaccine adjuvants such as aluminum salts, ...

Throughout life, our cells are constantly exposed to environmental and internal factors that can damage DNA. While such DNA ...

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...